* Exelixis Inc EXEL.OQ EXEL.O is expected to show a rise
in
quarterly revenue when it reports results on May 9.
* The Alameda California-based company is expected to
report a
18.8% increase in revenue to $423.077 million from $355.98
million a year ago, according to the mean estimate from 14
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Exelixis Inc is for
earnings of 15 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Exelixis
Inc is
$25, above its last closing price of $19.48.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.11 -0.12 -0.09 Beat 26.9
Sep. 30 2022 0.18 0.19 0.23 Beat 22.2
Jun. 30 2022 0.16 0.19 0.22 Beat 17.6
Mar. 31 2022 0.14 0.14 0.21 Beat 47.7
Dec. 0.04 0.06 0.29 Beat 375.4
31 2021
Sep. 30 2021 0.16 0.17 0.12 Missed -27.7
Jun. 30 2021 0.06 0.06 0.30 Beat 393.2
Mar. 31 2021 0.03 0.03 0.00 Missed -100
This summary was machine generated May 6 at 02:08 GMT. All
figures in US dollars unless otherwise stated